Clinical Trials Browser

NIH × Ovarian Neoplasms × Dasatinib × Clear all

NCT02059265 2023-08-01

Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer

Phase 2 Terminated

35 enrolled 13 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms